The following transactions relate to bond investments of Livermore Laboratories. The company's fiscal year ends on December $31.\backslash$table$[[$No$,$Date,General,,Debit,Credit$],[1,$July $01,2024,$Investment in bonds,$2,28,000,000,],[,$Discount on investment in bonds,$\backslash$theta $,,600,000],[,$Cash,$\backslash$theta $,,27,400,000],[2,$October $01,2024,$Investment in bonds,$0,42,000,000,],[,$Premium on investment in bonds,V$,2,552,000,],[,$Interest receivable,$\backslash$theta $,1,960,000,],[,$Cash,$\backslash$theta $,,46,512,000],[3,$December $01,202,$Cash,grad,$2,940,000,],[,$Premium on investment in bonds,$\backslash$theta $,,20,000\backslash$times $],[,$Interest receivable,$2,,1,960,000],[,$Interest revenue,$2,,2,940,000\backslash$times $],[4,$December $31,202,$Interest receivable,$0,1,470,000\backslash$times $,],[,$Discount on investment in bonds,$2,,],[,$Interest revenue,$2,,1,470,000\backslash$times $],[5,$December $31,202,$Interest receivable,$2,,],[,$Premium on investment in bonds,$\backslash$theta $,,],[,$Interest revenue,$2,,],[6,$January $01,2025,$Cash,$0,,],[,$Interest receivable,$2,,]]\backslash$table$[[7,$June $01,2025,$Cash,$0,,],[,,$Premium on investment in bonds,$2,,],[,,$Interest receivable,$2,,],[,,$Interest revenue,$2,,],[8,$July $01,2025,$Cash,$2,,],[,,$Discount on investment in bonds,$2,,],[,,$Interest revenue,Q$,,],[9,$September $01,202,$Interest receivable,V$,,],[,,$Premium on investment in bonds,$0,,],[,,$Interest revenue,$2,,],[10,$September $01,202,$Cash,V$,,],[,,$Loss on sale of investments,$2,,],[,,$Investment in bonds,$2,,],[,,$Premium on investment in bonds,$(,,],[,,$Interest receivable,$0,,],[11,$December $01,202,$Cash,V$,,],[,,$Premium on investment in bonds,$2,,],[,,$Interest revenue,$(,,],[12,$December $31,202,$Interest receivable,V$,,],[,,$Discount on investment in bonds,$(,,],[,,$Interest revenue,$0,,]]$ Complete this question by entering your answers in the tabs below.

Required $1$

Required $2$

By how much will Livermore Labs' earnings increase in each of the three years as a result of these investments? $($Ignore

income taxes.$)$

Note: Do not round intermediate calculations. Enter your answers in whole dollars.$\backslash$table$[[16,$February $28,2026,$Cash,,,$],[,,$Loss on sale of investments,,,$],[,,$Investment in bonds,,,$],[,,$Premium on investment in bonds,,,$],[,,$Interest receivable,,,$],[,,,,,],[17,$December $31,202\backslash$epsi $,$Interest receivable,,,$],[,,$Discount on investment in bonds,,,$],[,,$Interest revenue,,,$]]$

Livermore uses the straight$-$line method to determine interest. July $1$ Purchased $$28$ million of Bracecourt Corporation $12\%$ debentures, due in $20$ years $($June $30,2044),$ for $$27\mathrm{.}4$ million.October $1$ Purchased $$42$ million of $14\%$ Framm Pharmaceuticals debentures, due May $31,2034,$ for $$44,552,000$ plus accrued interest.December $1$ Received interest on the Framm bonds.

December $31$ Accrued interest.

$2025$ June $1$ Received interest on the Framm bonds.September $1$ Sold $$21\mathrm{.}0$ million of the Framm bonds at $102$ plus accrued interest.December $31$ Accrued interest$\mathrm{.}2026$

January $1$ Received interest on the Bracecourt bonds.

February $28$ Sold the remainder of the Framm bonds at $103$ plus accrued interest.

December $31$ Accrued interest.

Required:

Prepare the appropriate journal entries for these long$-$term bond investments.

By how much will Livermore Labs' earnings increase in each of the three years as a result of these investments? $($Ignore income

taxes.$)$